Monoclonal antibodies for the therapy of cancer (original) (raw)
Grafting of "Abbreviated" Complementarity-Determining Regions Containing Specificity-Determining Residues Essential for Ligand Contact to Engineer a Less Immunogenic Humanized Monoclonal Antibody
E. Padlan, Ameurfina Santos
The Journal of Immunology, 2002
View PDFchevron_right
Advances in the assessment and control of the effector functions of therapeutic antibodies
Thomas Arroll
Nature Reviews Drug Discovery, 2011
View PDFchevron_right
Antibodies, Fc receptors and cancer
Falk Nimmerjahn
Current Opinion in Immunology, 2007
View PDFchevron_right
Monoclonal Antibodies:A promising treatment for cancer
Alex Lardas
View PDFchevron_right
Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors
Gianfranco Cocorullo
Expert Opinion on Biological Therapy, 2011
View PDFchevron_right
Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields
John Maher
Frontiers in Immunology
View PDFchevron_right
Cloning, isolation and characterization of human tumor in situ monoclonal antibodies
Jeffry Watkins
Cancer Immunol Immunother, 2002
View PDFchevron_right
Human antibodies as next generation therapeutics
Marc van Dijk
Current Opinion in Chemical Biology, 2001
View PDFchevron_right
Functional Consequences of Insertions and Deletions in the Complementarity-determining Regions of Human Antibodies
Mats Ohlin
Journal of Biological Chemistry, 2002
View PDFchevron_right
Monoclonal Antibodies, Human, Engineered
Tracy Daniels, Gustavo Helguera
View PDFchevron_right
Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent
S. Beiboer
Journal of Molecular Biology, 2000
View PDFchevron_right
Mechanistic considerations for the use of monoclonal antibodies for cancer therapy
Patrick Glassman
Cancer biology & medicine, 2014
View PDFchevron_right
Monoclonal Antibody Therapy for Cancer
Grégory ADAMS
Annual Review of Medicine, 2003
View PDFchevron_right
Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent 1 1 Edited by I. A. Wilson
Rob Roovers
J Mol Biol, 2000
View PDFchevron_right
Enhancing the potency of therapeutic monoclonal antibodies via Fc optimization
Sergey Gorlatov
Advances in Enzyme Regulation, 2008
View PDFchevron_right
Single-domain antibodies as building blocks for novel therapeutics
Serge Muyldermans
Current Opinion in Pharmacology, 2008
View PDFchevron_right
The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions
Carrie Wagner, Harlan Weisman
Molecular Immunology, 1995
View PDFchevron_right
Characterization of a mouse-human chimeric antibody to a cancer-associated antigen
Augusto Barbera
International Journal of Cancer, 1992
View PDFchevron_right
Advances in the applications of monoclonal antibodies in clinical oncology
Stephen Cobbold, Mike Clark
Br. J. Cancer, 1986
View PDFchevron_right
The interactions of therapeutic antibodies with Fc receptors
Marcello Albanesi
Immunology Letters, 2012
View PDFchevron_right
Enhanced binding of low-affinity antibodies interacting simultaneously with targeted cell surface molecules and Fc receptor
Michael Hansen
Tissue Antigens, 2002
View PDFchevron_right
Specificity analysis of human monoclonal antibodies reactive with cell surface and intracellular antigens
Richard Cote
Proceedings of the National Academy of Sciences, 1986
View PDFchevron_right
Monoclonal antibodies and therapy of human cancers
Alberto Horenstein
Biotechnology Advances, 2000
View PDFchevron_right
of Multivalent Antibodies Design, Construction, and In Vitro Analyses
jacques gaudreault
2017
View PDFchevron_right
Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy
Ellen Vitetta
Cancer research, 1994
View PDFchevron_right
Monoclonal Antibody
Tapan Dutta
View PDFchevron_right
Therapeutic antibodies: successes, limitations and hopes for the future
Patrick Chames
British Journal of Pharmacology, 2009
View PDFchevron_right
A new mouse expressing human Fcγ receptors to better predict therapeutic efficacy of human anti-cancer antibodies
Patrizia Mondello
Leukemia, 2017
View PDFchevron_right
Description of a New Monoclonal Antibody, FC-2.15, Reactive with Human Breast Cancer and other Human Neoplasias
Laura Bover
The International Journal of Biological Markers, 1994
View PDFchevron_right
Monoclonal antibody therapeutics and apoptosis
Daniel Pereira
Oncogene, 2003
View PDFchevron_right
REVIEW REVIEW Antibodies
Inga-lill Mårtensson
2015
View PDFchevron_right
Development of antibody surrogates for the treatment of cancers and autoimmune disease
Thomas Kodadek
Current Opinion in Chemical Biology, 2010
View PDFchevron_right
Monoclonal Antibody in Quest of Cancer Therapeutics
abdullah saeed
View PDFchevron_right
Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity
nicolas frans
Nature Biotechnology, 2005
View PDFchevron_right
Twenty Years with Monoclonal Antibodies: State of the art-Where do we go?
Rauni Norrlund
Acta Oncologica, 1996
View PDFchevron_right